NEW YORK (GenomeWeb News) — Celera said today it has closed its acquisition of Berkeley HeartLab for around $195 million in cash.
Celera said the acquisition, originally announced in early September, will begin to bring in accretive earnings in the second half of fiscal 2008.
Celera president Kathy Ordonez said the company was attracted to BHL for its existing products and for its potential to develop new predictive molecular diagnostics for cardiovascular disease.
BHL has around 300 employees, including 110 lab staffers and about 80 field-based representatives and clinical educators, Celera said.